Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Codagenix Awarded PATH Subcontract to Develop Stabilized Novel Oral Polio Vaccine Candidates

Summary by Benzinga
Codagenix will develop nOPV-maxSD vaccine candidates with its proprietary synthetic biology to further improve genetic stability FARMINGDALE, N.Y., July 22, 2025 /PRNewswire/ -- Codagenix Inc., a clinical-stage biotechnology company, today announced a collaboration agreement with PATH funded by a grant from the Gates Foundation to apply its proprietary synthetic biology technology to fortify novel oral poliovirus vaccine (nOPV) strains against r…

1 Articles

BenzingaBenzinga
Center

Codagenix Awarded PATH Subcontract to Develop Stabilized Novel Oral Polio Vaccine Candidates

Codagenix will develop nOPV-maxSD vaccine candidates with its proprietary synthetic biology to further improve genetic stability FARMINGDALE, N.Y., July 22, 2025 /PRNewswire/ -- Codagenix Inc., a clinical-stage biotechnology company, today announced a collaboration agreement with PATH funded by a grant from the Gates Foundation to apply its proprietary synthetic biology technology to fortify novel oral poliovirus vaccine (nOPV) strains against r…

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Tuesday, July 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Farmingdale, New York icon

Farmingdale, New York

News
For You
SearchBlindspotLocal